Advisors Asset Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.79M | Sell |
12,200
-194
| -2% | -$43.5K | 0.05% | 496 |
|
|
2025
Q4 | $2.64M | Buy |
12,394
+1,785
| +17% | +$369K | 0.04% | 513 |
|
|
2025
Q3 | $2.11M | Buy |
10,609
+137
| +1% | +$25.6K | 0.04% | 584 |
|
|
2025
Q2 | $1.81M | Buy |
10,472
+1,282
| +14% | +$209K | 0.03% | 593 |
|
|
2025
Q1 | $1.43M | Buy |
9,190
+949
| +12% | +$136K | 0.03% | 655 |
|
|
2024
Q4 | $1.13M | Buy |
8,241
+3,499
| +74% | +$460K | 0.02% | 713 |
|
|
2024
Q3 | $708K | Buy |
4,742
+894
| +23% | +$121K | 0.01% | 824 |
|
|
2024
Q2 | $525K | Buy |
+3,848
| New | +$524K | 0.01% | 879 |
|
|
2023
Q4 | – | Sell |
-5,519
| Closed | -$517K | – | 1404 |
|
|
2023
Q3 | $517K | Sell |
5,519
-98
| -2% | -$9.17K | 0.01% | 894 |
|
|
2023
Q2 | $501K | Sell |
5,617
-270
| -5% | -$23.5K | 0.01% | 930 |
|
|
2023
Q1 | $631K | Sell |
5,887
-254
| -4% | -$29.1K | 0.01% | 882 |
|
|
2022
Q4 | $750K | Sell |
6,141
-9,675
| -61% | -$1.12M | 0.02% | 841 |
|
|
2022
Q3 | $1.63M | Sell |
15,816
-933
| -6% | -$88.5K | 0.03% | 560 |
|
|
2022
Q2 | $1.56M | Sell |
16,749
-22
| -0.1% | -$2.07K | 0.03% | 596 |
|
|
2022
Q1 | $1.97M | Buy |
16,771
+520
| +3% | +$60.2K | 0.03% | 590 |
|
|
2021
Q4 | $2.19M | Buy |
16,251
+1,443
| +10% | +$215K | 0.03% | 571 |
|
|
2021
Q3 | $2.36M | Sell |
14,808
-212
| -1% | -$29K | 0.04% | 543 |
|
|
2021
Q2 | $1.98M | Buy |
15,020
+1,240
| +9% | +$165K | 0.03% | 601 |
|
|
2021
Q1 | $1.78M | Buy |
13,780
+5,267
| +62% | +$800K | 0.03% | 634 |
|
|
2020
Q4 | $1.42M | Buy |
8,513
+3,916
| +85% | +$648K | 0.02% | 677 |
|
|
2020
Q3 | $709K | Buy |
4,597
+560
| +14% | +$80.5K | 0.01% | 809 |
|
|
2020
Q2 | $597K | Buy |
4,037
+2,693
| +200% | +$370K | 0.01% | 847 |
|
|
2020
Q1 | $151K | Buy |
+1,344
| New | +$175K | ﹤0.01% | 1158 |
|
Other funds holding ASND
RCM
ACA
